We are live on ! Find out more
WF

Welch & Forbes Portfolio holdings

AUM $8.23B
1-Year Est. Return 17.62%
This Fund
S&P 500
This Quarter Est. Return
-1.2%
1 Year Est. Return
+17.62%
3 Year Est. Return
+73.71%
5 Year Est. Return
+105.59%
10 Year Est. Return
+384.92%
AUM
$3.88B
AUM Growth
+$134M
Cap. Flow
+$219M
Cap. Flow %
5.65%
Top 10 Hldgs %
22.53%
Holding
368
New
30
Increased
108
Reduced
154
Closed
12

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$51M
2
CB icon
Chubb
CB
+$44M
3
ABT icon
Abbott
ABT
+$37.6M
4
AFL icon
Aflac
AFL
+$31M
5
T icon
AT&T
T
+$16.9M

Sector Composition

Rank Sector Weight
1 Healthcare 19.2%
2 Technology 17.48%
3 Financials 12.88%
4 Industrials 9.97%
5 Consumer Discretionary 8.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CELG
51
DELISTED
Celgene Corp
CELG
$26.1M 0.67%
292,344
+17,468
+6% +$1.68M
GSK icon
52
GSK
GSK
$104B
$25.7M 0.66%
525,510
-926
-0.2% -$43.1K
FTV icon
53
Fortive
FTV
$17.7B
$25.5M 0.66%
521,767
+10,351
+2% +$493K
SWK icon
54
Stanley Black & Decker
SWK
$14.9B
$25.5M 0.66%
166,374
+22,325
+15% +$3.62M
COF icon
55
Capital One
COF
$129B
$25.2M 0.65%
263,031
-5,261
-2% -$524K
BUD icon
56
AB InBev
BUD
$166B
$23.9M 0.61%
216,941
-3,931
-2% -$436K
CGNX icon
57
Cognex
CGNX
$10.4B
$23.1M 0.6%
444,451
-27,492
-6% -$1.63M
COST icon
58
Costco
COST
$423B
$22.4M 0.58%
118,716
+2,589
+2% +$488K
BAC icon
59
Bank of America
BAC
$433B
$22.3M 0.57%
742,483
+13,620
+2% +$428K
TD icon
60
Toronto Dominion Bank
TD
$198B
$21.7M 0.56%
382,391
-914
-0.2% -$53.5K
EXPD icon
61
Expeditors International
EXPD
$21.8B
$20.8M 0.54%
328,187
-7,740
-2% -$497K
KO icon
62
Coca-Cola
KO
$381B
$20.7M 0.53%
476,001
+4,490
+1% +$202K
DOV icon
63
Dover
DOV
$27.5B
$20.4M 0.53%
257,706
-978
-0.4% -$80.1K
SVC
64
Service Properties Trust
SVC
$1.04B
$20.2M 0.52%
159,808
+3,414
+2% +$459K
CHD icon
65
Church & Dwight Co
CHD
$23.1B
$20.2M 0.52%
400,149
+12,892
+3% +$635K
LQD icon
66
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.3B
$20M 0.51%
170,075
-2,800
-2% -$331K
VZ icon
67
Verizon
VZ
$193B
$19.4M 0.5%
405,392
-2,386
-0.6% -$120K
CSCO icon
68
Cisco
CSCO
$448B
$18.7M 0.48%
437,136
-5,094
-1% -$216K
PFF icon
69
iShares Preferred and Income Securities ETF
PFF
$13.3B
$18.7M 0.48%
497,209
+10,620
+2% +$399K
USB icon
70
US Bancorp
USB
$98B
$18.2M 0.47%
361,161
-7,024
-2% -$384K
IGSB icon
71
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
$18.2M 0.47%
351,272
-52,780
-13% -$2.75M
KYN icon
72
Kayne Anderson Energy Infrastructure Fund
KYN
$2.45B
$18.2M 0.47%
1,105,216
+6,663
+0.6% +$122K
FTSL icon
73
First Trust Senior Loan Fund ETF
FTSL
$2.32B
$17.9M 0.46%
372,651
+3,568
+1% +$172K
CVS icon
74
CVS Health
CVS
$134B
$17.8M 0.46%
285,873
-88,119
-24% -$6.32M
OMC icon
75
Omnicom Group
OMC
$21.8B
$17.6M 0.45%
241,910
+3,897
+2% +$292K

Similar funds

Welch & Forbes's Q1 2018 Portfolio in Review

As of Q1 2018, Welch & Forbes held 368 positions worth $3.88B, up 3.6% from $3.75B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Welch & Forbes deployed $219M of net new capital in Q1 2018, opening 30 new positions and adding to 108 existing holdings. Its largest new stake was AbbVie: 464,710 shares worth $44M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 17% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was CVS Health, an estimated $6.32M trimmed.

  • Welch & Forbes's largest Q1 2018 buy was AbbVie: 464,710 shares worth $44M.
  • Welch & Forbes added most to Johnson & Johnson in Q1 2018, an estimated $8.9M increase.
  • Welch & Forbes's biggest Q1 2018 reduction was CVS Health, cutting an estimated $6.32M.
  • Welch & Forbes fully exited Easterly Acquisition Corp in Q1 2018, selling an estimated $10M.
  • Welch & Forbes's ten largest holdings make up 23% of its $3.88B portfolio in Q1 2018.
  • Welch & Forbes opened 30 new positions and closed 12 in Q1 2018.
  • Welch & Forbes's portfolio value rose 3.6% quarter-over-quarter to $3.88B.

Based on Welch & Forbes's 13F filing for Q1 2018, filed 12 Apr 2018.